Shows & Panels
- The 2014 Big Picture on Cyber Security
- AFCEA Answers
- Ask the CIO
- Connected Government
- Consolidating Mission-critical Systems
- Constituent Servicing
- The Data Privacy Imperative: Safeguarding Sensitive Data
- Eliminating the Pitfalls: Steps to Virtualization in Government
- Federal Executive Forum
- Federal Tech Talk
- Government Cloud Brokerage: Who, What, When, Where, Why?
- Government Mobility
- The Intersection: Where Technology Meets Transformation
- Maximizing ROI Through Data Center Consolidation
- Mobile Device Management
- The Modern Federal Threat Landscape
- Moving to the Cloud. What's the best approach for me
- Navigating Tough Choices in Government Cloud Computing
- Satellite Communications: Acquiring SATCOM in Tight Times
- Transformative Technology: Desktop Virtualization in Government
- Understanding the Intersection of Customer Service and Security in the Cloud
Shows & Panels
Search Tags: HIV
The number of newly diagnosed HIV and AIDS cases in the District fell for the second straight year in 2009, but the nation's capital still faces an epidemic infection rate connected to the disease, a city report says.
Sunday will mark 30 years since the Centers for Disease Control and Prevention reported the first cases of the disease that would become known as AIDS.
Part 1 of an interview with Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health
Part 2 of an interview with Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health
The D.C. mayor has directed acting Attorney General Irvin Nathan to return the two SUVs City Council Chairman Kwame Brown ordered for himself.
DoD is on a mission to develop a preventive HIV vaccine for U.S. military personnel and for the global community.
Scientists led by the National Institutes of Health have discovered antibodies that will prevent most HIV strains from infecting human cells. Two potent human antibodies have been found to stop more than 90 percent of known global HIV strains from infecting human cells in the lab. Scientists have even demonstrated how one of the disease-fighting proteins is able to do it. They found the antibodies using a novel molecular device that homes in on the specific cells that make antibodies that fight HIV. According to the scientists, the antibodies could be used to design improved HIV vaccines, or could be further developed to prevent or treat HIV infection. Moreover, the method used to find the antibodies could be used to find therapeutic antibodies for other infectious diseases.